Bringing the fundamentals into focus…
Back to Neurocrine Biosciences, Inc.
How Neurocrine Biosciences, Inc. stacks up
NBIX · against 123 other Healthcare companies of similar size
Growth
87/ 100
Near the top of its peers.
Ranked #19 of 124 · scores higher than 83% of peers
Bars: peers in each 10-point band of the growth score21 peers with a growth score of 80–89, including NBIX · Click a bar to see the companies
Why growth scores 87?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its revenue growth, earnings per share growth and 3-year revenue growth, which are stronger than most Healthcare peers.
- faster growth in earnings per share: stronger than 86% of peers. Earnings per share growth: 97.6% vs peer median 9.8%
- faster revenue growth over three years: stronger than 86% of peers. 3-year revenue growth: 26.3% vs peer median 5.8%
- faster revenue growth over the last year: stronger than 87% of peers. Revenue growth: 34.4% vs peer median 6.1%
Metric by metric
Position: dot = NBIX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | NBIX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 125 reported | 34.4% | 9.9% | 82% | 33% | |
| Earnings per share growthHigher is better · 91 reported | 97.6% | 18.3% | 88% | 33% | |
| 3-year revenue growthHigher is better · 120 reported | 26.3% | 10.7% | 82% | 33% |
Ranking by growth score
Top 5 and the companies ranked around NBIX| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.8B USD | 99 | 31 | |
| 2 | 9.3B USD | 98 | 64 | |
| 3 | 14.87T KRW (≈$10.7B) | 97 | 76 | |
| 3 | 21.4B USD | 97 | 67 | |
| 5 | 16.5B USD | 96 | 37 | |
| 15 | 4.61T JPY (≈$31.3B) | 89 | 76 | |
| 15 | 13.8B USD | 89 | 54 | |
| 18 | 14.0B USD | 88 | 31 | |
| 19 | 27.5B NZD (≈$16.5B) | 87 | 69 | |
| 19 | 16.8B USD | 87 | 75 | |
| 19 | 20.0B AUD (≈$13.2B) | 87 | 77 | |
| 19 | 10.4B USD | 87 | 70 | |
| 23 | 43.30T KRW (≈$31.2B) | 86 | 68 | |
| 23 | 14.4B USD | 86 | 71 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score